| scholarly article | Q13442814 |
| P2093 | author name string | Rajesh Kumar | |
| Richard Graves | |||
| Nirbhay Kumar | |||
| Tarun Mandal | |||
| Dibyadyuti Datta | |||
| Geetha P Bansal | |||
| Grace Ledet | |||
| Shana Robinson | |||
| P2860 | cites work | Malaria transmission blocked by immunisation with gametes of the malaria parasite | Q42979953 |
| A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains | Q43525538 | ||
| Malaria transmission-blocking vaccines | Q43796267 | ||
| Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward | Q44144794 | ||
| The 230-kDa gamete surface protein of plasmodium falciparum is also a target for transmission-blocking antibodies | Q44146561 | ||
| Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity | Q44156482 | ||
| Crystallization and preliminary X-ray analysis of the Plasmodium vivax sexual stage 25 kDa protein Pvs25, a transmission-blocking vaccine candidate for malaria | Q44159925 | ||
| The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms | Q44166687 | ||
| Biodegradable microparticles with different release profiles: effect on the immune response after a single administration via intranasal and intramuscular routes. | Q45812465 | ||
| Effect of different ratios of high and low molecular weight PLGA blend on the characteristics of pentamidine microcapsules | Q47431902 | ||
| Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies | Q69090852 | ||
| Helminth antigens modulate TLR-initiated dendritic cell activation | Q81111451 | ||
| Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission | Q21134576 | ||
| Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. | Q33217285 | ||
| Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. | Q33350210 | ||
| A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli | Q33485233 | ||
| Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial | Q34043843 | ||
| Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle | Q34341570 | ||
| Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum. | Q34548828 | ||
| A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice | Q35048518 | ||
| Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex | Q35132063 | ||
| Pfs230: from malaria transmission-blocking vaccine candidate toward function | Q35548285 | ||
| Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25. | Q35575993 | ||
| Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum | Q36348052 | ||
| Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates | Q36539678 | ||
| Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice | Q36670217 | ||
| Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles | Q36943309 | ||
| Nanovehicular intracellular delivery systems | Q37058812 | ||
| Control to elimination: implications for malaria research | Q37257297 | ||
| Biodegradable polymeric nanoparticles based drug delivery systems | Q37603750 | ||
| Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding | Q37713285 | ||
| Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses | Q37785952 | ||
| Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns | Q37800358 | ||
| Key roles of adjuvants in modern vaccines | Q38169040 | ||
| Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres | Q38549187 | ||
| Biodegradation of PLA/GA polymers: increasing complexity | Q40498395 | ||
| Recombinant Pfs25 protein of plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals | Q42006764 | ||
| Successful immunization against the sexual stages of Plasmodium gallinaceum | Q42979860 | ||
| P433 | issue | 12 | |
| P921 | main subject | nanoparticle | Q61231 |
| Plasmodium falciparum | Q311383 | ||
| P304 | page(s) | 3827-3836 | |
| P577 | publication date | 2015-06-26 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles | |
| P478 | volume | 32 |
| Q57295566 | A malaria vaccine adjuvant based on recombinant antigen binding to liposomes |
| Q90706801 | Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2)2 of Plasmodium falciparum in a Mouse Model |
| Q39062396 | Impact of the Charge Ratio on the In Vivo Immunogenicity of Lipoplexes |
| Q36079818 | Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles |
| Q47251697 | Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity |
| Q26750929 | Recent Advances in Subunit Vaccine Carriers |
Search more.